P3 Health Partners (PIII) Competitors $0.22 0.00 (0.00%) (As of 12/11/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends PIII vs. VMD, PSNL, LFMD, SERA, BDSX, QIPT, EUDA, XGN, BNR, and ENZShould you be buying P3 Health Partners stock or one of its competitors? The main competitors of P3 Health Partners include Viemed Healthcare (VMD), Personalis (PSNL), LifeMD (LFMD), Sera Prognostics (SERA), Biodesix (BDSX), Quipt Home Medical (QIPT), EUDA Health (EUDA), Exagen (XGN), Burning Rock Biotech (BNR), and Enzo Biochem (ENZ). These companies are all part of the "healthcare" industry. P3 Health Partners vs. Viemed Healthcare Personalis LifeMD Sera Prognostics Biodesix Quipt Home Medical EUDA Health Exagen Burning Rock Biotech Enzo Biochem P3 Health Partners (NASDAQ:PIII) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and community ranking. Do analysts recommend PIII or VMD? P3 Health Partners presently has a consensus target price of $2.38, suggesting a potential upside of 969.82%. Given P3 Health Partners' higher possible upside, equities analysts clearly believe P3 Health Partners is more favorable than Viemed Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score P3 Health Partners 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Viemed Healthcare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Do insiders & institutionals believe in PIII or VMD? 7.8% of P3 Health Partners shares are owned by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are owned by institutional investors. 17.9% of P3 Health Partners shares are owned by company insiders. Comparatively, 20.0% of Viemed Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is PIII or VMD more profitable? Viemed Healthcare has a net margin of 4.87% compared to P3 Health Partners' net margin of -6.95%. Viemed Healthcare's return on equity of 8.72% beat P3 Health Partners' return on equity.Company Net Margins Return on Equity Return on Assets P3 Health Partners-6.95% -71.31% -11.93% Viemed Healthcare 4.87%8.72%6.48% Does the MarketBeat Community prefer PIII or VMD? P3 Health Partners received 1 more outperform votes than Viemed Healthcare when rated by MarketBeat users. However, 42.86% of users gave Viemed Healthcare an outperform vote while only 26.67% of users gave P3 Health Partners an outperform vote. CompanyUnderperformOutperformP3 Health PartnersOutperform Votes426.67% Underperform Votes1173.33% Viemed HealthcareOutperform Votes342.86% Underperform Votes457.14% Which has more volatility & risk, PIII or VMD? P3 Health Partners has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500. Comparatively, Viemed Healthcare has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500. Does the media refer more to PIII or VMD? In the previous week, P3 Health Partners had 1 more articles in the media than Viemed Healthcare. MarketBeat recorded 2 mentions for P3 Health Partners and 1 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 1.87 beat P3 Health Partners' score of 1.43 indicating that Viemed Healthcare is being referred to more favorably in the news media. Company Overall Sentiment P3 Health Partners Positive Viemed Healthcare Very Positive Which has higher earnings and valuation, PIII or VMD? Viemed Healthcare has lower revenue, but higher earnings than P3 Health Partners. P3 Health Partners is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioP3 Health Partners$1.48B0.05-$57.77M-$0.84-0.26Viemed Healthcare$183.01M1.89$10.24M$0.2732.96 SummaryViemed Healthcare beats P3 Health Partners on 14 of the 19 factors compared between the two stocks. Ad Investing DailyEx-Lawyer turns $50k into $5 million tradingHe was a lawyer by day, secret trader by night...or in this case by lunch… With nothing but a laptop and a lunch break, he cracked the stock market's code. Today, this former lawyer has grown a modest $50k trading account into a mind-blowing $5 million sum.You can access this rare, eye-opening interview here. Get P3 Health Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for PIII and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PIII vs. The Competition Export to ExcelMetricP3 Health PartnersHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$79.66M$964.06M$5.26B$9.28BDividend YieldN/A1.83%5.12%3.95%P/E Ratio-0.2637.66135.4217.64Price / Sales0.054.041,236.47141.09Price / Cash2.4625.3735.5735.65Price / Book0.493.054.824.95Net Income-$57.77M-$3.80M$119.12M$225.72M7 Day Performance0.91%-1.40%1.53%1.51%1 Month Performance-43.14%1.33%-0.54%4.96%1 Year Performance-80.00%343.53%33.11%29.01% P3 Health Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PIIIP3 Health Partners3.8197 of 5 stars$0.22flat$2.38+969.8%-80.2%$79.66M$1.48B-0.26500Short Interest ↓Positive NewsVMDViemed Healthcare2.708 of 5 stars$8.57-0.6%N/A+13.4%$333.72M$183.01M33.33630Positive NewsPSNLPersonalis4.2619 of 5 stars$4.00-3.6%$6.81+70.3%+186.3%$282.60M$73.48M0.00400Positive NewsLFMDLifeMD2.1191 of 5 stars$5.82+4.3%$11.50+97.6%-29.5%$252.06M$152.55M0.00230Analyst ForecastGap UpSERASera Prognostics0.4968 of 5 stars$7.43+1.1%N/A+102.8%$250.91M$310,000.000.00120BDSXBiodesix3.5939 of 5 stars$1.31-3.3%$3.06+134.5%-18.2%$189.84M$49.09M-3.41220Short Interest ↑QIPTQuipt Home Medical2.0874 of 5 stars$2.77+3.0%$6.25+125.6%-38.6%$119.36M$221.74M0.001,200Upcoming EarningsNews CoverageEUDAEUDA Health0.6311 of 5 stars$4.43+2.3%N/A+340.2%$109.11M$3.71M0.002Short Interest ↑Positive NewsGap UpXGNExagen4.8852 of 5 stars$4.42-2.9%$7.00+58.4%+208.1%$77.97M$52.55M-4.84220BNRBurning Rock Biotech1.5937 of 5 stars$6.74-5.9%N/A-11.0%$69.02M$75.70M0.001,390Short Interest ↓ENZEnzo Biochem1.2975 of 5 stars$1.06+0.9%N/A-17.6%$55.36M$31.91M0.00520Analyst ForecastGap Down Related Companies and Tools Related Companies VMD Competitors PSNL Competitors LFMD Competitors SERA Competitors BDSX Competitors QIPT Competitors EUDA Competitors XGN Competitors BNR Competitors ENZ Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PIII) was last updated on 12/12/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredEx-Lawyer turns $50k into $5 million tradingHe was a lawyer by day, secret trader by night...or in this case by lunch… With nothing but a laptop and a ...Investing Daily | SponsoredWant to Start Investing? It’s Easier Than You Think!Many people think you need a lot of money to start investing—but that’s simply not true. Andy Tanner, Rich ...The Cashflow Academy | SponsoredPrepare Now Before This Looming $2 Trillion D.C. ShockMillions of traders could get blindsided by this election-year shock on December 18th… And if you do nothin...Timothy Sykes | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share P3 Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PIII Stock Alerts